CellMark Biopharma, LLC & Lexium International LLC
The FTC brought a federal court action against CellMark Biopharma, LLC and Lexium International LLC in the Middle District of Florida for deceptive and misleading conduct related to weight loss products. The case was handled as a dual enforcement action with the DOJ under consumer protection and health care fraud frameworks. The matter was closed as of June 21, 2017. Specific marketing claims are not detailed in the available case summary, but the action centered on deceptive weight loss advertising.
Required actions (1)
Federal Trade Commission v. Lexium International LLC, and Cellmark Biopharma, LLC
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker